CN107095300A - A kind of biological nutrition compound composition of auxiliary treatment diabetes - Google Patents
A kind of biological nutrition compound composition of auxiliary treatment diabetes Download PDFInfo
- Publication number
- CN107095300A CN107095300A CN201710134651.3A CN201710134651A CN107095300A CN 107095300 A CN107095300 A CN 107095300A CN 201710134651 A CN201710134651 A CN 201710134651A CN 107095300 A CN107095300 A CN 107095300A
- Authority
- CN
- China
- Prior art keywords
- extract
- powder
- parts
- chromium
- treatment diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 238000011282 treatment Methods 0.000 title claims abstract description 32
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 28
- 230000035764 nutrition Effects 0.000 title claims abstract description 26
- 150000001875 compounds Chemical class 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 77
- 239000000843 powder Substances 0.000 claims abstract description 71
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 61
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 61
- 239000011651 chromium Substances 0.000 claims abstract description 61
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 47
- 235000014459 Sorbus Nutrition 0.000 claims abstract description 40
- 241001092391 Sorbus Species 0.000 claims abstract description 40
- 241000222336 Ganoderma Species 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000008103 glucose Substances 0.000 claims abstract description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 88
- 239000007788 liquid Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 20
- 229930003944 flavone Natural products 0.000 claims description 15
- 235000011949 flavones Nutrition 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 150000004676 glycans Chemical class 0.000 claims description 14
- 229920001282 polysaccharide Polymers 0.000 claims description 14
- 239000005017 polysaccharide Substances 0.000 claims description 14
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 13
- 150000002212 flavone derivatives Chemical class 0.000 claims description 13
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 12
- 235000015097 nutrients Nutrition 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 11
- 230000008676 import Effects 0.000 claims description 10
- 241000233866 Fungi Species 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 230000002829 reductive effect Effects 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000003102 growth factor Substances 0.000 claims description 6
- 239000008236 heating water Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 150000003384 small molecules Chemical class 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000010899 nucleation Methods 0.000 claims description 5
- 241001145025 Saussurea involucrata Species 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 238000005119 centrifugation Methods 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 210000004185 liver Anatomy 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 206010022489 Insulin Resistance Diseases 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 33
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 16
- 239000003814 drug Substances 0.000 description 15
- 239000002609 medium Substances 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 240000008397 Ganoderma lucidum Species 0.000 description 5
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 208000005156 Dehydration Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 208000002249 Diabetes Complications Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010012655 Diabetic complications Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000167880 Hirundinidae Species 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 102000003746 Insulin Receptor Human genes 0.000 description 2
- 108010001127 Insulin Receptor Proteins 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000015111 chews Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 231100000206 health hazard Toxicity 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 108010026951 Short-Acting Insulin Proteins 0.000 description 1
- 229940123958 Short-acting insulin Drugs 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 241001609931 bacterium 20 Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of biological nutrition compound composition of auxiliary treatment diabetes, is prepared from by the raw material of following parts by weight:Black 50 70 parts of fruit Sorbus alnifloria extract;Herba Saussureae Involueratae extract 15 25 parts of powder of original;15 25 parts of Ganoderma rich in chromium mycelium powder;Above raw material amounts to 100 parts.The present invention can improve insulin sensitivity, and softening and dredging blood vessel improves liver and renal glucose sugar generation and storage capacity, maintains carbohydate metabolism balance, while reducing or offsetting the side effect of traditional treatment diabetes.
Description
Technical field
The present invention relates to technical field of nutritional food, and in particular to a kind of biological nutrition formula group of auxiliary treatment diabetes
Compound.
Background technology
Diabetes are the metabolic diseases occurred by the Other Risk Factors such as heredity, environment, behavior collective effect, are also tight
One of four major class chronic diseases of China's residents ' health are threatened again.Wound of the diabetes except causing body and mind to patient and its friends and family
Evil, also brings huge economic loss.China puts into (25,000,000,000 dollars) of nearly 173,400,000,000 RMB every year is used for diabetes management;
Direct medical expense for diabetes accounts for the 13% of Chinese medical expenditure.
The World Health Organization (WHO) gave a warning the World Hygiene Day in 2016:China there are about 1.1 hundred million patient of diabetes
Person, if not taking action as early as possible, it is contemplated that the numeral will increase to 1.5 hundred million people in the year two thousand forty.
Type 1 diabetes are also referred to as adolescent diabetes, be mainly characterized in that in patient's body can not generate enough insulin, it is necessary to
Daily use of exogenous insulin;Diabetes B is common in the elderly, is that body can not be caused effectively using insulin, accounts for
Diabetic's number accounts for the 90% of patient populations.The diabetes patient that the course of disease is longer, control is poor, be often accompanied by various complication or
With disease.
The diabetes B illness rate of China was in explosive growth in past more than 20 years, and it is not main reason is that
Healthy lifestyles, the dietary structure and shortage of such as high sugared and high fat are moved, and cause Chinese overweight and fat ratio increasingly
Rise.Diabetes and diabetic complication cause nearly 1,000,000 people dead every year;It is a concern that wherein nearly 40% death
For premature death (below 70 years old in population).China's diabetic's number is numerous, prevention and control situation very severe.
In the management of diabetes, melbine is recommended in the diabetes guide that many countries and international organization formulate at present
As the basic medication in the fiest-tire medication and drug combination of diabetes B Patients' rights hyperglycaemia, Body weight loss can be made, reduced
Type 2 Diabetes Mellitus Patients with Obesity cardiovascular event and death.
The major side effects of melbine are gastrointestinal reaction.Gastrointestinal symptom sees 10% patient, can have abdominal discomfort,
Apocleisis, nausea, diarrhoea, occasionally there is dry or metallic taste, and also only a few people can induce lactic acidosis.
Also sulfonylureas and benzoic acid derivative class promote to secrete agent, if improper use can cause hypoglycemia, particularly exist
The infull person of gerontal patient and Liver and kidney function;Sulfonylurea drugs may further result in increased weight.
For OHA failure or partial failure patient it is necessary to be continuing with oral hypoglycemic drug, and imitate in injecting
Or protamine zine insulin.Short-acting insulin can be used for the severe diabetes such as drip-feed treatment DKA;Type 1 diabetes once
Diagnosis, still needs to lifelong subcutaneous insulin and controls;Diabetes B can use insulin complement treatment or replacement therapy.Such medicine can be sent out
Wave blood sugar reducing function, and significantly reduce body weight, enhancing insulin secretion, glucagon suppression secrete and can delay gastric emptying,
Food-intake is reduced with the appetite-suppressing by central.But side effect has hypoglycemic reaction and gastrointestinal side effect.
From the point of view of the method for the treatment of diabetes at present, effect is really good, but side effect is really many, using not only effectively but also without pair
The naturopathy of effect, aids in or substitutes traditional medicine and insulin therapy, it has also become the craving of numerous diabetics.
The content of the invention
For defect of the prior art, the present invention provides a kind of biological nutrition formula combination of auxiliary treatment diabetes
Thing.
A kind of biological nutrition compound composition of auxiliary treatment diabetes, is prepared from by the raw material of following parts by weight:
Black 50-70 parts of fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract 15-25 parts of powder of original;
15-25 parts of Ganoderma rich in chromium mycelium powder;
Above raw material amounts to 100 parts.
In the present invention, as a kind of perferred technical scheme, a kind of biological nutrition formula combination of auxiliary treatment diabetes
Thing, is prepared from by the raw material of following parts by weight:
Black 60 parts of fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract 20 parts of powder of original;
20 parts of Ganoderma rich in chromium mycelium powder.
In the present invention, as a kind of perferred technical scheme, the content of chromium is 0.1- in the composition
0.05wt%.Chromium is trivalent chromium, the edible Organic Chromium of state approval.
In the present invention, as a kind of perferred technical scheme, the composition is prepared using following methods:
Weigh the former powder of black fruit Sorbus alnifloria extract, Herba Saussureae Involueratae extract, Ganoderma rich in chromium mycelium powder, tabletting, packaging.
Such as during tabletting, those skilled in the art can also can as needed add necessary auxiliary material with direct tablet compressing, micro-
Crystalline cellulose etc..
Tabletting is 0.5g/, daily 6 when taking, chews or swallows.Infant, children and fungi polysaccharide allergy sufferers are not
Preferably take.
In the present invention, as a kind of perferred technical scheme, the black fruit Sorbus alnifloria extract is prepared using following methods:Take
The fruit of black fruit Sorbus alnifloria is crushed, and is 1 according to solid-liquid ratio:5-10 adds distilled water, is warming up to 50-65 DEG C, is kept for 3-5 minutes, so
It is 1 to add solid-liquid ratio afterwards:3-5 ethanol solution, adjustment pH is 3.5-4.5, and in the case where temperature is 32-35 DEG C, heating water bath extracts 2-
3 hours, extract solution is then centrifuged into 30-45min under 2000-2800 revs/min of speed, and be warming up to 45-48 DEG C of decompression
Concentration, is then spray-dried, obtains black fruit Sorbus alnifloria extract.
In the present invention, as a kind of perferred technical scheme, the volume ratio of ethanol and water is 1 in ethanol solution:1.
In the present invention, as a kind of perferred technical scheme, the preparation method of Herba Saussureae Involueratae extract original powder is as follows:By day
Mountain saussurea involucrata tissue culture is dried 8-10 hours using 70-80 DEG C of cryogenic dewatering of oven, obtains below water content 8wt%
Herba Saussureae Involueratae tissue culture dry powder, Herba Saussureae Involueratae tissue culture dry powder is crushed to 80 mesh, 80wt% ethanol is utilized
Solution low temperature is extracted, and feed liquid weight ratio is 1:100, by extract solution in 65-70 DEG C of ultrafiltration membrance filter, residue is removed, biology is obtained
Extracting flavonoids stoste, extracts stoste cryogenic vacuum by biological flavone and concentrates, and reclaims ethanol, and in 65-70 DEG C of spray drying, obtain
Herba Saussureae Involueratae extract original powder.Wherein, Herba Saussureae Involueratae culture is aseptically, by vitro plant organ, tissue, thin
Born of the same parents, embryo or Protoplast cuhnre are cultivated under conditions of artificial control on the culture medium manually prepared, organize it
Or cell is bred and then obtained product is cultivated in progress as required, is ripe prior art.
In the present invention, as a kind of perferred technical scheme, low temperature, which is extracted, to be referred to extract at 25-35 DEG C.
In the present invention, as a kind of perferred technical scheme, the preparation method of the Ganoderma rich in chromium mycelium powder is as follows:
First stage zymotechnique flow:Fluid nutrient medium high-temperature sterilization, accesses liquid lucidum strain after cooling, import
100L first class seed pots, 25 DEG C of ferment at constant temperature under aerobic aseptic condition are cultivated 5 days, secondary seed tank are imported, aerobic sterile
Under the conditions of 25 DEG C of constant temperature continue to cultivate 4 days, productivity fermentation tank is then introduced into, equally in 25 DEG C of constant temperature under aerobic aseptic condition
Culture 4 days, fermentation ends obtain fermenation raw liquid;
Second stage extraction process flow:Fermenation raw liquid is boiled 2 hours using distilled water at 90-100 DEG C, is then introduced into
Disk centrifugal pump, retains supernatant, removes residue, and cryogenic vacuum is concentrated 2-4 hours, obtains 15wt% polysaccharide concentrates, then
Using 95wt% ethanol solution alcohol precipitations 6-8 hours, small-molecule substance is removed, is retained based on fungi polysaccharide, is reclaimed ethanol, utilize spray
Mist seasoning obtains Ganoderma rich in chromium mycelium powder.
In the present invention, as a kind of perferred technical scheme, the fluid nutrient medium includes purified water, glucose, albumen
Peptone, dusty yeast, micro- trivalent chromium and growth factor.
In the present invention, as a kind of perferred technical scheme, high-temperature sterilization is temperature to be maintained at 125 DEG C 1-2 hours.
In the present invention, as a kind of perferred technical scheme, cryogenic vacuum concentration is concentrated in vacuo at 20-25 DEG C.
In the present invention, black fruit Sorbus alnifloria (i.e. Black Box Tracing) belongs to perennial machaka, is a kind of emerging small berries.Really
It is real to be rich in flavonoids and liposoluble ingredient, the ability with stronger antioxidation activity and removing free radical.It is big according to Chinese agriculture
Learn Food Science and tested with key lab of functional food Beijing of nutrition engineering college and shown:Content of mineral substances in fresh fruit reaches
580mg/100g, wherein potassium content are particularly pertinent, and sodium is micro.B group micro-elements are complete abundant, carotenoid (beta carotene, jade
Cream-coloured matter etc.) content is higher.Polyphenols is main functional activity material in black fruit Sorbus alnifloria, and Determination of Polyphenols is 3440-
7849mg/100g (dry weight).In the fruit of black fruit Sorbus alnifloria, containing abundant anthocyanidin, flavones, (fresh fruit content is up to 0.25%-
0.35%), polyphenol, also containing the material such as multivitamin and mineral element.Polyphenol is to improve the structure of capillary and blood vessel
With the very important material of function, additionally aid stimulation and improve the circulatory system.Anthocyanidin and flavones are able to maintain that the heart of people
The health of dirty and body.Research shows that black fruit Sorbus alnifloria leaf extract can stimulate PC12 cells and L929 cells to glucose
Intake, significantly reduces the diabetes rat of streptozotocin (STZ) induction and the blood sugar level of normal rat.In clinical application research
It is middle to find, black fruit Sorbus alnifloria fruit juice is taken after 3 months, and the fasting blood-glucose of type 2 diabetes patient is substantially reduced, it is sugared in patients blood plasma
Change hemoglobin, lipid and total cholesterol level also to decrease, this shows that black fruit Sorbus alnifloria can be used for the auxiliary of diabetic
Therapeutic diet.
Containing abundant biological flavone in Herba Saussureae Involueratae extract original powder, biological flavone main function is exactly to dissolve blood cake blood
Bolt, quick effectively cracking separation patch, quickly removes thrombus, patch, cleans the toxin and lipid rubbish of blood kind, by recovering
The pliability of capillary, makes the capillary of hardening recover elasticity.Saussurea involucrata culture is not only containing close with natural snow lotus
Active component, and also there is many pharmacological activity suitable therewith.Its main pharmacological analgesia, anti-inflammatory, antirheumatic;Suppression
Platelet aggregation processed, hypoglycemic, reducing blood lipid, improvement blood circulation;There is adjustment effect to immune system.
The pharmaceutical component of ganoderma lucidum mycelium powder enriches very much, and wherein active ingredient includes GL-B, ganoderma lucidum polypeptide, triterpene
Class, 16 kinds of amino acid (wherein containing seven kinds of essential amino acids), protein, steroid, mannitol, coumarin glycosides, alkaloid,
Organic acid (main contain fumaric acid), and trace element Ge, Fe, Ca, Mn, Zn, etc..Ganoderma lucidum has bidirectional modulation work to human body
With controlling disease, be related to each system such as cardiovascular and cerebrovascular, digestion, nerve, endocrine, breathing, motion, especially to tumour, liver
Lesion, insomnia and the preventive and therapeutic effect of aging are very notable.Micro- Organic Chromium is one of the essential trace elements of the human body, people
Internal chromium is nearly all trivalent, and it is very stable, and containing about chromium 6mg (milligram) in human body, it is universally present in skeleton, flesh
Among meat, hair, skin, hypodermis, major organs (except lung) and body fluid.The blood sugar reducing function mechanism of chromium is can to increase pancreas islet
Disorderly adhesion, increase insulin receptor quantity, the phosphorylation of increase insulin receptor with acceptor etc..Suction of the human body to inorganic chromium
Utilization rate is received extremely low, less than 1%;Human body is to the utilization rate of Organic Chromium up to 10~25%.The μ g of normal adult's demand 20~50
(microgram)/day, children, pregnant woman and old man are 50~110 μ g/ days, and diabetic and obese people are 50~200 μ g/ days.
The biological nutrition compound composition that the present invention is provided is the basic principle composition constituted according to traditional Chinese medical prescription compatibility
's.The medicine of composition prescription can be divided into monarch drug in a prescription, ministerial drug by its effect played in prescription, adjutant, make medicine, referred to as monarch, minister,
Help, make.Wherein, monarch drug in a prescription is black fruit Sorbus alnifloria extract, and primary treatment is played to diabetes, can remove free radical, Tianshan Mountains snow
Lotus extract original powder can play dissolving blood cake thrombus, reduce the effect of blood viscosity as ministerial drug, auxiliary monarch drug in a prescription treatment;
Ganoderma lucidum mycelium powder coordinates monarch-minister drug treatment accompanying symptoms, improves hematoglobin protein synthesis capability as adjutant;And ganoderma lucidum mycelium powder
In the trivalent chromium that is rich in can then play effect that collaboration insulin participates in human body sugar and lipid-metabolism together.It is several above
Raw material is mutually cooperateed with and played a role jointly, plays the auxiliary therapeutic action to diabetes.And the whole preferably natural plants of formula,
Ecological safety, rich in nutritional ingredient, without any potential health hazard.By rational dialectical compatibility, gradually reduce or replace
In generation, takes the use of depressor and insulin injection, and eliminates or reduce the toxic side effect that medicine is brought, and reaches what slow disease was controlled soon
Effect.
Inventor thinks:Optimization nutrition treatment is the primary measure of all kinds Diabetes Foundation treatment.By controlling meals
Eat the intake of gross energy, the reasonable various nutriments of equilibrium assignment, to meet the physiological requirement of glycometabolism.If everyone passes through
Health diet and increase amount of exercise, can reduce risk.In the case of no diabetic complication, by six months
To the adjustment of 1 year, blood glucose can recover normal.
Special diet demand of the invention aiming at diabetes, the Polyphenols extracted using modern biotechnology science and technology fermentation,
Flavonoids, fungi polysaccharide class and formula that is related micro- and preparing.The formula of these active ingredients, realizes following effect:
Improve insulin sensitivity, softening and dredging blood vessel improves liver and renal glucose sugar generation and storage capacity, maintains carbohydate metabolism
Balance.Reduce or offset simultaneously the side effect of traditional treatment diabetes.Moreover, inventor draws by a large amount of experiments repeatedly
Specific extraction, fermentation process, the active ingredient of each component fully can be extracted and played a role, it is ensured that this several component
The effect of synergy.
Due to using above technical scheme, the invention has the advantages that:
1st, ecological safety, is formulated the raw materials used new resource food for ratifying production all from health ministry, does not have
Any potential health hazard;
2nd, formulation product sense organ and mouthfeel come from the true qualities of plant, and no chemistry addition allows people to be willing to accept.
3rd, the active constituent content of product is high, and effect is strong, and the slow disease that can reach auxiliary treatment controls effect soon;
4th, raw material needed for product is secure, there is production base, there is bioengineering production line, there is new-product development laboratory,
The market demand can be ensured;
5th, the present invention is both adapted to diabetes mellitus prevention, and the disease that all kinds glycosuria is adapted to again is repaired and auxiliary treatment;
6th, during the formulation product is eaten, without any side effect.
Embodiment
Technical solution of the present invention is described in detail below in conjunction with embodiment.Following examples are only used for more clear
Illustrate to Chu technical scheme, therefore be only used as example, and can not be limited the scope of the invention with this.
Embodiment 1
A kind of biological nutrition compound composition of auxiliary treatment diabetes, is prepared from by the raw material of following parts by weight:It is black
70 parts of fruit Sorbus alnifloria extract;Herba Saussureae Involueratae extract 15 parts of powder of original;15 parts of Ganoderma rich in chromium mycelium powder;Above raw material amounts to 100
Part.The content of chromium is 0.1wt% in the composition.Chromium is trivalent chromium, the edible Organic Chromium of state approval.
Wherein, black fruit Sorbus alnifloria extract is adopted prepares with the following method:
Take the fruit of black fruit Sorbus alnifloria to crush, be 1 according to solid-liquid ratio:5 add distilled water, are warming up to 50 DEG C, are kept for 3 minutes,
Then it is 1 to add solid-liquid ratio:The volume ratio of ethanol and water is 1 in 3 ethanol solution, ethanol solution:1, adjustment pH is 3.5,
Temperature is extracted 2 hours for heating water bath at 32 DEG C, extract solution is then centrifuged into 30min under 2000 revs/min of speed, and rise
Warm to 45 DEG C are concentrated under reduced pressure, and are then spray-dried, obtain black fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract original powder is adopted to be prepared with the following method:
By Herba Saussureae Involueratae tissue culture using 70 DEG C of dehydrations of oven, low temperature drying 8 hours, are obtained at 35 DEG C
Below water content 8wt% Herba Saussureae Involueratae tissue culture dry powder, 80 mesh are crushed to by Herba Saussureae Involueratae tissue culture dry powder, profit
With the solution of 80wt% ethanol, low temperature is extracted at 25 DEG C, and feed liquid weight ratio is 1:100, by extract solution in 65 DEG C of milipore filter mistakes
Filter, remove residue, obtain biological flavone and extract stoste, biological flavone is extracted into stoste cryogenic vacuum concentrates, recovery ethanol, and
65 DEG C of spray drying, obtain the former powder of Herba Saussureae Involueratae extract;
The preparation method of Ganoderma rich in chromium mycelium powder is as follows:
First stage zymotechnique flow:Fluid nutrient medium includes purified water, glucose, peptone, dusty yeast, micro member
Plain trivalent chromium and growth factor, maintain temperature to carry out high-temperature sterilization in 1 hour fluid nutrient medium, are accessed after cooling at 125 DEG C
Liquid lucidum strain, imports 100L first class seed pots, and 25 DEG C of ferment at constant temperature under aerobic aseptic condition are cultivated 5 days, import two grades
Seeding tank, 25 DEG C of constant temperature continue to cultivate 4 days under aerobic aseptic condition, productivity fermentation tank are then introduced into, equally aerobic
Lower 25 DEG C of aseptic condition is incubated 4 days, and fermentation ends obtain fermenation raw liquid;
Second stage extraction process flow:Fermenation raw liquid is boiled 2 hours using distilled water at 90 DEG C, dish-style is then introduced into
Centrifugal pump, retains supernatant, removes residue, and cryogenic vacuum is concentrated 2 hours at 20 DEG C, obtains 15wt% polysaccharide concentrates, so
95wt% ethanol solutions alcohol precipitation is utilized afterwards 6 hours, remove small-molecule substance, retain based on fungi polysaccharide, reclaim ethanol, utilize spray
Mist seasoning obtains Ganoderma rich in chromium mycelium powder.
The composition is prepared using following methods:
Weigh the former powder of black fruit Sorbus alnifloria extract, Herba Saussureae Involueratae extract, Ganoderma rich in chromium mycelium powder, tabletting, packaging.
Embodiment 2
A kind of biological nutrition compound composition of auxiliary treatment diabetes, is prepared from by the raw material of following parts by weight:It is black
50 parts of fruit Sorbus alnifloria extract;Herba Saussureae Involueratae extract 25 parts of powder of original;25 parts of Ganoderma rich in chromium mycelium powder;Above raw material amounts to 100
Part.The content of chromium is 0.05wt% in the composition.Chromium is trivalent chromium, edible organic of state approval
Chromium.
Wherein, black fruit Sorbus alnifloria extract is adopted prepares with the following method:
Take the fruit of black fruit Sorbus alnifloria to crush, be 1 according to solid-liquid ratio:10 add distilled water, are warming up to 65 DEG C, are kept for 5 minutes,
Then it is 1 to add solid-liquid ratio:The volume ratio of ethanol and water is 1 in 5 ethanol solution, ethanol solution:1, adjustment pH is 4.5,
Temperature is extracted 3 hours for heating water bath at 35 DEG C, extract solution is then centrifuged into 45min under 2800 revs/min of speed, and rise
Warm to 48 DEG C are concentrated under reduced pressure, and are then spray-dried, obtain black fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract original powder is adopted to be prepared with the following method:
By Herba Saussureae Involueratae tissue culture using 80 DEG C of dehydrations of oven, low temperature drying 10 hours, are obtained at 45 DEG C
To below water content 8wt% Herba Saussureae Involueratae tissue culture dry powder, Herba Saussureae Involueratae tissue culture dry powder is crushed to 80 mesh,
Using the solution of 80wt% ethanol, low temperature is extracted at 35 DEG C, and feed liquid weight ratio is 1:100, by extract solution in 70 DEG C of milipore filter mistakes
Filter, remove residue, obtain biological flavone and extract stoste, biological flavone is extracted into stoste cryogenic vacuum concentrates, recovery ethanol, and
70 DEG C of spray drying, obtain the former powder of Herba Saussureae Involueratae extract;
The preparation method of Ganoderma rich in chromium mycelium powder is as follows:
First stage zymotechnique flow:Fluid nutrient medium includes purified water, glucose, peptone, dusty yeast, micro member
Plain trivalent chromium and growth factor, maintain temperature to carry out high-temperature sterilization in 2 hours fluid nutrient medium, are accessed after cooling at 125 DEG C
Liquid lucidum strain, imports 100L first class seed pots, and 25 DEG C of ferment at constant temperature under aerobic aseptic condition are cultivated 5 days, import two grades
Seeding tank, 25 DEG C of constant temperature continue to cultivate 4 days under aerobic aseptic condition, productivity fermentation tank are then introduced into, equally aerobic
Lower 25 DEG C of aseptic condition is incubated 4 days, and fermentation ends obtain fermenation raw liquid;
Second stage extraction process flow:Fermenation raw liquid is boiled 2 hours using distilled water at 100 DEG C, dish is then introduced into
Formula centrifugal pump, retains supernatant, removes residue, and cryogenic vacuum is concentrated 4 hours at 25 DEG C, obtains 15wt% polysaccharide concentrates,
Then utilize 95wt% ethanol solutions alcohol precipitation 8 hours, remove small-molecule substance, retain based on fungi polysaccharide, reclaim ethanol, utilize
Spray drying process obtains Ganoderma rich in chromium mycelium powder.
The composition is prepared using following methods:
Weigh the former powder of black fruit Sorbus alnifloria extract, Herba Saussureae Involueratae extract, Ganoderma rich in chromium mycelium powder, tabletting, packaging.
Embodiment 3
A kind of biological nutrition compound composition of auxiliary treatment diabetes, is prepared from by the raw material of following parts by weight:By
The raw material of following parts by weight is prepared from:Black 60 parts of fruit Sorbus alnifloria extract;Herba Saussureae Involueratae extract 20 parts of powder of original;Ganoderma rich in chromium bacterium
20 parts of filament powder.The content of chromium is 0.1-0.05wt% in the composition.Chromium is trivalent chromium, and state approval can be with
Edible Organic Chromium.
Wherein, black fruit Sorbus alnifloria extract is adopted prepares with the following method:
Take the fruit of black fruit Sorbus alnifloria to crush, be 1 according to solid-liquid ratio:8 add distilled water, are warming up to 55 DEG C, are kept for 4 minutes,
Then it is 1 to add solid-liquid ratio:The volume ratio of ethanol and water is 1 in 4 ethanol solution, ethanol solution:1, adjustment pH is 4, in temperature
Spend and extracted 2.5 hours for heating water bath at 33 DEG C, extract solution is then centrifuged into 40min under 2500 revs/min of speed, and rise
Warm to 46 DEG C are concentrated under reduced pressure, and are then spray-dried, obtain black fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract original powder is adopted to be prepared with the following method:
By Herba Saussureae Involueratae tissue culture using 75 DEG C of dehydrations of oven, low temperature drying 9 hours, are obtained at 40 DEG C
Below water content 8wt% Herba Saussureae Involueratae tissue culture dry powder, 80 mesh are crushed to by Herba Saussureae Involueratae tissue culture dry powder, profit
With the solution of 80wt% ethanol, low temperature is extracted at 30 DEG C, and feed liquid weight ratio is 1:100, by extract solution in 68 DEG C of milipore filter mistakes
Filter, remove residue, obtain biological flavone and extract stoste, biological flavone is extracted into stoste cryogenic vacuum concentrates, recovery ethanol, and
68 DEG C of spray drying, obtain the former powder of Herba Saussureae Involueratae extract;
The preparation method of Ganoderma rich in chromium mycelium powder is as follows:
First stage zymotechnique flow:Fluid nutrient medium includes purified water, glucose, peptone, dusty yeast, micro member
Plain trivalent chromium and growth factor, maintain temperature to carry out high-temperature sterilization in 1.5 hours fluid nutrient medium, cooling is followed by 125 DEG C
Enter liquid lucidum strain, import 100L first class seed pots, 25 DEG C of ferment at constant temperature under aerobic aseptic condition are cultivated 5 days, import two
Level seeding tank, 25 DEG C of constant temperature continue to cultivate 4 days under aerobic aseptic condition, are then introduced into productivity fermentation tank, are equally having
Lower 25 DEG C of oxygen aseptic condition is incubated 4 days, and fermentation ends obtain fermenation raw liquid;
Second stage extraction process flow:Fermenation raw liquid is boiled 2 hours using distilled water at 95 DEG C, dish-style is then introduced into
Centrifugal pump, retains supernatant, removes residue, and cryogenic vacuum is concentrated 3 hours at 23 DEG C, obtains 15wt% polysaccharide concentrates, so
95wt% ethanol solutions alcohol precipitation is utilized afterwards 7 hours, remove small-molecule substance, retain based on fungi polysaccharide, reclaim ethanol, utilize spray
Mist seasoning obtains Ganoderma rich in chromium mycelium powder.
The composition is prepared using following methods:
Weigh the former powder of black fruit Sorbus alnifloria extract, Herba Saussureae Involueratae extract, Ganoderma rich in chromium mycelium powder, tabletting, packaging.
Embodiment 4
A kind of biological nutrition compound composition of auxiliary treatment diabetes, is prepared from by the raw material of following parts by weight:It is black
60 parts of fruit Sorbus alnifloria extract;Herba Saussureae Involueratae extract 15 parts of powder of original;25 parts of Ganoderma rich in chromium mycelium powder.Chromium member in the composition
The content of element is 0.1-0.05wt%.Chromium is trivalent chromium, the edible Organic Chromium of state approval.
Wherein, black fruit Sorbus alnifloria extract is adopted prepares with the following method:
Take the fruit of black fruit Sorbus alnifloria to crush, be 1 according to solid-liquid ratio:5 add distilled water, are warming up to 65 DEG C, are kept for 3 minutes,
Then it is 1 to add solid-liquid ratio:The volume ratio of ethanol and water is 1 in 5 ethanol solution, ethanol solution:1, adjustment pH is 4, in temperature
Spend and extracted 2 hours for heating water bath at 35 DEG C, extract solution is then centrifuged into 30min under 2100 revs/min of speed, and heat up
It is concentrated under reduced pressure, is then spray-dried to 48 DEG C, obtains black fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract original powder is adopted to be prepared with the following method:
By Herba Saussureae Involueratae tissue culture using 72 DEG C of dehydrations of oven, low temperature drying 8 hours, are obtained at 45 DEG C
Below water content 8wt% Herba Saussureae Involueratae tissue culture dry powder, 80 mesh are crushed to by Herba Saussureae Involueratae tissue culture dry powder, profit
With the solution of 80wt% ethanol, low temperature is extracted at 35 DEG C, and feed liquid weight ratio is 1:100, by extract solution in 65 DEG C of milipore filter mistakes
Filter, remove residue, obtain biological flavone and extract stoste, biological flavone is extracted into stoste cryogenic vacuum concentrates, recovery ethanol, and
67 DEG C of spray drying, obtain the former powder of Herba Saussureae Involueratae extract;
The preparation method of Ganoderma rich in chromium mycelium powder is as follows:
First stage zymotechnique flow:Fluid nutrient medium includes purified water, glucose, peptone, dusty yeast, micro member
Plain trivalent chromium and growth factor, maintain temperature to carry out high-temperature sterilization in 1.3 hours fluid nutrient medium, cooling is followed by 125 DEG C
Enter liquid lucidum strain, import 100L first class seed pots, 25 DEG C of ferment at constant temperature under aerobic aseptic condition are cultivated 5 days, import two
Level seeding tank, 25 DEG C of constant temperature continue to cultivate 4 days under aerobic aseptic condition, are then introduced into productivity fermentation tank, are equally having
Lower 25 DEG C of oxygen aseptic condition is incubated 4 days, and fermentation ends obtain fermenation raw liquid;
Second stage extraction process flow:Fermenation raw liquid is boiled 2 hours using distilled water at 92 DEG C, dish-style is then introduced into
Centrifugal pump, retains supernatant, removes residue, and cryogenic vacuum is concentrated 3.5 hours at 25 DEG C, obtains 15wt% polysaccharide concentrates,
Then utilize 95wt% ethanol solutions alcohol precipitation 7 hours, remove small-molecule substance, retain based on fungi polysaccharide, reclaim ethanol, utilize
Spray drying process obtains Ganoderma rich in chromium mycelium powder.
The composition is prepared using following methods:
Weigh the former powder of black fruit Sorbus alnifloria extract, Herba Saussureae Involueratae extract, Ganoderma rich in chromium mycelium powder, tabletting, during tabletting, plus
Enter microcrystalline cellulose as auxiliary material, packaging.
Measure of merit embodiment
30 mild diabetes patients (blood glucose is 7.9 or so on an empty stomach) are randomly divided into tri- groups of A, B, C, wherein, A groups clothes
The biological nutrition compound composition provided with the present invention, each three of morning and afternoon, chews or swallows by daily 6;It is most that B groups, which are taken,
Conventional gram sugar profit;C groups do not take any medicament.
As a result it is as follows:
Project | Persistently take average blood sugar after 5 weeks | Disable average blood sugar after 3 weeks |
A groups | 5.7 | 6.2 |
B groups | 4.5 | 6.7 |
C groups | 7.9 | 8.1 |
As can be seen from the above results:
The biological nutrition compound composition that the present invention is provided has relatively more significant effect for regulation hyperglycaemia, although clothes
With the blood sugar decreasing effect of period not as a gram sugar profit, but after being discontinued, blood glucose rise is slower, also illustrates have more for blood glucose
Long-acting adjustment effect.
Use embodiment
Certain is shut out, man, 50 years old, people from Haikou, physical examination blood glucose on July 8 (empty stomach) 7.48 (normal 3.9-6) in 2016;Paddy
Aminoacyl transpeptidase 188 (normal 10-60), belongs to diabetic, takes the composition of the present invention, daily 6, July 9 in 2016
Day starts to eat, and 8.1 is down to 6.3 on an empty stomach by original after first quarter moon, effect is obvious.
Finally it should be noted that:Various embodiments above is merely illustrative of the technical solution of the present invention, rather than its limitations;To the greatest extent
The present invention is described in detail with reference to foregoing embodiments for pipe, it will be understood by those within the art that:Its according to
The technical scheme described in foregoing embodiments can so be modified, or which part or all technical characteristic are entered
Row equivalent substitution;And these modifications or replacement, the essence of appropriate technical solution is departed from various embodiments of the present invention technology
The scope of scheme, it all should cover among the claim of the present invention and the scope of specification.
Claims (10)
1. a kind of biological nutrition compound composition of auxiliary treatment diabetes, it is characterised in that by the raw material system of following parts by weight
It is standby to form:
Black 50-70 parts of fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract 15-25 parts of powder of original;
15-25 parts of Ganoderma rich in chromium mycelium powder;
Above raw material amounts to 100 parts.
2. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 1, it is characterised in that by
The raw material of following parts by weight is prepared from:
Black 60 parts of fruit Sorbus alnifloria extract;
Herba Saussureae Involueratae extract 20 parts of powder of original;
20 parts of Ganoderma rich in chromium mycelium powder.
3. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 1, it is characterised in that institute
The content for stating chromium in composition is 0.1-0.05wt%.
4. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 1, it is characterised in that institute
Composition is stated to prepare using following methods:
Weigh the former powder of black fruit Sorbus alnifloria extract, Herba Saussureae Involueratae extract, Ganoderma rich in chromium mycelium powder, tabletting, packaging.
5. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 1, it is characterised in that institute
Black fruit Sorbus alnifloria extract is stated to prepare using following methods:Take the fruit of black fruit Sorbus alnifloria to crush, be 1 according to solid-liquid ratio:5-10 is added
Distilled water, is warming up to 50-65 DEG C, is kept for 3-5 minutes, it is 1 then to add solid-liquid ratio:3-5 ethanol solution, adjustment pH is 3.5-
4.5, it is that heating water bath is extracted 2-3 hours at 32-35 DEG C in temperature, the then speed by extract solution at 2000-2800 revs/min
Lower centrifugation 30-45min, and be warming up to 45-48 DEG C and be concentrated under reduced pressure, then it is spray-dried, obtains black fruit Sorbus alnifloria extract.
6. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 5, it is characterised in that second
The volume ratio of ethanol and water is 1 in alcoholic solution:1.
7. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 1, it is characterised in that day
The preparation method of the former powder of mountain Saussurea involucrata extract is as follows:Herba Saussureae Involueratae tissue culture is utilized into 70-80 DEG C of dehydration of oven
Low temperature drying 8-10 hours, obtains below water content 8wt% Herba Saussureae Involueratae tissue culture dry powder, Herba Saussureae Involueratae tissue is trained
Support thing dry powder and be crushed to 80 mesh, extracted using the solution low temperature of 80wt% ethanol, feed liquid weight ratio is 1:100, extract solution is existed
65-70 DEG C of ultrafiltration membrance filter, removes residue, obtains biological flavone and extracts stoste, and it is dense that biological flavone is extracted into stoste cryogenic vacuum
Contracting, reclaims ethanol, and in 65-70 DEG C of spray drying, obtains the former powder of Herba Saussureae Involueratae extract.
8. the biological nutrition compound composition of a kind of auxiliary treatment diabetes according to claim 7, it is characterised in that low
Temperature, which is extracted, to be referred to extract at 25-35 DEG C.
9. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 1, it is characterised in that institute
The preparation method for stating Ganoderma rich in chromium mycelium powder is as follows:
First stage zymotechnique flow:Fluid nutrient medium high-temperature sterilization, accesses liquid lucidum strain after cooling, import 100L mono-
Level seeding tank, 25 DEG C of ferment at constant temperature under aerobic aseptic condition are cultivated 5 days, secondary seed tank are imported, under aerobic aseptic condition
25 DEG C of constant temperature continue to cultivate 4 days, productivity fermentation tank are then introduced into, equally in 25 DEG C incubated 4 under aerobic aseptic condition
My god, fermentation ends obtain fermenation raw liquid;
Second stage extraction process flow:Fermenation raw liquid is boiled 2 hours using distilled water at 90-100 DEG C, dish-style is then introduced into
Centrifugal pump, retains supernatant, removes residue, and cryogenic vacuum is concentrated 2-4 hours, is obtained 15wt% polysaccharide concentrates, is then utilized
95wt% ethanol solution alcohol precipitations 6-8 hours, remove small-molecule substance, retain based on fungi polysaccharide, reclaim ethanol, dry using spraying
Dry method obtains Ganoderma rich in chromium mycelium powder.
10. a kind of biological nutrition compound composition of auxiliary treatment diabetes according to claim 9, it is characterised in that
The fluid nutrient medium includes purified water, glucose, peptone, dusty yeast, micro- trivalent chromium and growth factor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710134651.3A CN107095300A (en) | 2017-03-08 | 2017-03-08 | A kind of biological nutrition compound composition of auxiliary treatment diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710134651.3A CN107095300A (en) | 2017-03-08 | 2017-03-08 | A kind of biological nutrition compound composition of auxiliary treatment diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107095300A true CN107095300A (en) | 2017-08-29 |
Family
ID=59674655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710134651.3A Pending CN107095300A (en) | 2017-03-08 | 2017-03-08 | A kind of biological nutrition compound composition of auxiliary treatment diabetes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107095300A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107668699A (en) * | 2017-10-27 | 2018-02-09 | 刘伟伟 | A kind of diabetes clinical nutrition formula and preparation method thereof |
CN108464500A (en) * | 2018-03-13 | 2018-08-31 | 武春风 | A kind of dietary composition of auxiliary adjustment hypertension |
CN108477597A (en) * | 2018-03-13 | 2018-09-04 | 武春风 | A kind of functional dietary composition adjusting glycometabolism |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101953867A (en) * | 2010-09-08 | 2011-01-26 | 新疆维吾尔自治区药物研究所 | Petroleum ether extract of saussurea involucrate, application preparation method and application thereof |
CN103598012A (en) * | 2013-11-16 | 2014-02-26 | 覃秀花 | Ganoderma lucidum mycelium and preparation method thereof |
CN104126785A (en) * | 2014-08-03 | 2014-11-05 | 及长城 | Composition with function of lowering blood sugar and preparation method thereof |
CN105106351A (en) * | 2015-09-10 | 2015-12-02 | 廊坊弘祥隆生物技术有限公司 | Production method of aronia melanocarpa extract |
-
2017
- 2017-03-08 CN CN201710134651.3A patent/CN107095300A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101953867A (en) * | 2010-09-08 | 2011-01-26 | 新疆维吾尔自治区药物研究所 | Petroleum ether extract of saussurea involucrate, application preparation method and application thereof |
CN103598012A (en) * | 2013-11-16 | 2014-02-26 | 覃秀花 | Ganoderma lucidum mycelium and preparation method thereof |
CN104126785A (en) * | 2014-08-03 | 2014-11-05 | 及长城 | Composition with function of lowering blood sugar and preparation method thereof |
CN105106351A (en) * | 2015-09-10 | 2015-12-02 | 廊坊弘祥隆生物技术有限公司 | Production method of aronia melanocarpa extract |
Non-Patent Citations (2)
Title |
---|
杨志孝等: "《灵芝菌株富铬性能的研究》", 《泰山医学院学报》 * |
陈红惠等: "《雪莲果叶黄酮的纯化工艺》", 《食品研究与开发》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107668699A (en) * | 2017-10-27 | 2018-02-09 | 刘伟伟 | A kind of diabetes clinical nutrition formula and preparation method thereof |
CN108464500A (en) * | 2018-03-13 | 2018-08-31 | 武春风 | A kind of dietary composition of auxiliary adjustment hypertension |
CN108477597A (en) * | 2018-03-13 | 2018-09-04 | 武春风 | A kind of functional dietary composition adjusting glycometabolism |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101624570B (en) | Method for cultivating cultured ganoderma lucidum with Chinese medicaments and method for preparing cultured ganoderma lucidum health-care product | |
CN104982928B (en) | A kind of japanese yew fruit health care ferment and preparation method thereof | |
CN104543834A (en) | Pumpkin powder with blood sugar reducing effect and preparation method thereof | |
CN108392519A (en) | A kind of hypoglycemic composition and its preparation and application | |
CN106244371A (en) | A kind of blood sugar lowering Rhizoma Polygonati grape health care wine and production technology thereof | |
CN105533688A (en) | Healthcare soft capsule with assistant blood-sugar reducing effect and preparation method thereof | |
CN104814105A (en) | Health care sweet potato pastry and preparation method thereof | |
CN107095300A (en) | A kind of biological nutrition compound composition of auxiliary treatment diabetes | |
CN102021101B (en) | Preparation method of healthy wine for preventing and treating cardiovascular and cerebrovascular diseases | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
CN103461585B (en) | Qi tonifying and health preserving herbal tea | |
CN107751993A (en) | A kind of antifatigue cream taste and preparation method thereof | |
CN102177993B (en) | Stomach-strengthening and digestion-promoting tea and preparation method thereof | |
CN107343889A (en) | A kind of peacilomyce hepiahi bacterium fermentation culture medium for being used to treat the 1st type or diabetes B | |
CN103380842A (en) | Method for preparing health care morning tea by utilizing whole plant powder of mung beans | |
CN103238757B (en) | Compound feed containing fermented cottonseed meal for chicken for eggs and preparation method thereof | |
KR101812725B1 (en) | Manufacturing method for pills using medical plants comprising ginseng and pills using medical plants comprising ginseng manufactured by the same | |
CN102578668A (en) | Beverage for assisting in reducing blood sugar | |
CN104017715A (en) | Passion fruit vinegar and preparation method thereof | |
CN102090637A (en) | Collagen-containing compound nutritious powder | |
CN103005264A (en) | Chitosan oligosaccharide-containing healthcare food and preparation method thereof | |
CN105695236A (en) | Formula and production process for health maintenance and healthcare wine | |
CN102125129B (en) | Health care tea | |
CN107616491A (en) | A kind of functional food for being used to prevent and treat diabetes | |
CN107737280A (en) | Chinese medicine composition for treating diabetes and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170829 |
|
RJ01 | Rejection of invention patent application after publication |